Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-29 22:38:26 - browse：7

Apellis Pharmaceuticals said Tuesday that it had identified “internal structural variations” in a type of needle used by doctors to prepare syringes of its eye disease drug Syfovre as a possible cause of severe eye inflammation reported in patients receiving the treatment — but the company stopped short of definitively linking the needle to the cases.

Additionally, Apellis confirmed one additional case of the severe and potentially blinding side effect, known as retinal occlusive vasculitis, or ROV, that occurred in May. But with thousands of more Syfovre eye injections also performed, the overall frequency of ROV remains unchanged and rare, even with the added scrutiny and increased physician monitoring.

Apellis shares rose 30% to $40 in Wednesday’s pre-market trading on the growing belief amongst investors that Syfovre’s safety crisis is abating.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Custom gene therapy hints at new path for rare disease treatments

explore

WSS

AstraZeneca to buy developer of next

Asbestos, a deadly carcinogen, banned by EPA

Cosmetics set for new safety regulation. Why the industry is on board

FDA approves RSV monoclonal antibody for infants, toddlers

FDA approves RSV monoclonal antibody for infants, toddlers

Group opposing PBM reform sets lobbying record

Wikipedia

Wikipedia

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Methadone treatment changes are coming. Do they go far enough?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Duchenne breakthrough therapy leaves behind pioneering families

Medicare has a new plan to address drug shortages

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Doctors find melanoma drugs effective against rare brain cancer

In age of alternative facts, a scholarly course on calling out crap

Key House panel plots a new health care package

focus

STAT Virtual Event: The State of Biosimilars: What to Watch

Stop the failed accountable care organization experiment

Doctors find melanoma drugs effective against rare brain cancer

FDA approves RSV monoclonal antibody for infants, toddlers

Medicare to cover more brain scans for Alzheimer’s patients

Methadone treatment changes are coming. Do they go far enough?

hotspot

focus

explore

focus